SANTA CLARA, Calif., June 6, 2024 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in growing and advertising expertise services and products to healthcare suppliers to fight power ailments, immediately introduced that it has bought a further 247 bitcoins for an combination $17 million in money, inclusive of charges and bills.
As of June 6, 2024, Semler holds a complete of 828 bitcoins, which have been acquired for an combination $57 million, inclusive of charges and bills.
“Semler stays centered on our two methods of increasing our healthcare enterprise and buying and holding bitcoin,” mentioned Doug Murphy-Chutorian, MD, Semler Scientific’s chief govt officer. “The corporate now holds 828 bitcoins, underscoring our view that bitcoin is a compelling funding and may function a dependable retailer of worth. We are going to proceed to pursue our technique of buying bitcoins with money.”
About Semler Scientific, Inc:
Semler Scientific, Inc. develops, manufactures and markets progressive services and products to fight power ailments. Its flagship product, QuantaFlo®, which is patented and cleared by the U.S. Meals and Drug Administration (FDA), is a fast point-of-care check that measures arterial blood circulation within the extremities. The QuantaFlo check aids within the prognosis of cardiovascular ailments, equivalent to peripheral arterial illness (PAD), and Semler Scientific is looking for a brand new 510(okay) clearance for expanded indications. QuantaFlo is utilized by healthcare suppliers to judge their affected person’s danger of mortality and main hostile cardiovascular occasions (MACE). Semler Scientific additionally invests in bitcoin and has adopted bitcoin as its main treasury reserve asset. Additional details about Semler Scientific might be discovered at www.semlerscientific.com.
Ahead-Trying Statements
This press launch comprises “forward-looking” statements. Such statements might be recognized by, amongst different issues, using forward-looking language such because the phrases “consider,” “objective,” “could,” “will,” “intend,” “anticipate,” “anticipate,” “estimate,” “undertaking,” “would,” “may” or phrases with comparable that means or the negatives of those phrases or by the dialogue of technique or intentions. The forward-looking statements on this launch embrace specific or implied statements concerning the brand new bitcoin technique, the acquisition of further bitcoin with money, and the growth of its healthcare enterprise, amongst others. Such forward-looking statements are topic to quite a few dangers and uncertainties that might trigger Semler Scientific’s precise outcomes to vary materially from these mentioned right here, equivalent to dangers inherent with investing in bitcoin, together with bitcoin‘s volatility; danger of implementing a brand new treasury technique; danger that insurance policy and different prospects won’t proceed to license its cardiovascular testing merchandise; danger of modifications within the reimbursement panorama for its prospects together with associated to the CMS price announcement; danger of acquiring a brand new 510(okay) clearance for expanded indications; together with these different danger components detailed in Semler Scientific’s filings with the Securities and Alternate Fee. These forward-looking statements contain assumptions, estimates, and uncertainties that mirror present inner projections, expectations or beliefs. There might be no assurance that such statements will show to be correct, and precise outcomes and future occasions may differ materially from these anticipated in such statements. All forward-looking statements contained on this press launch are certified of their entirety by these cautionary statements and the danger components described above. Moreover, all such statements are made as of the date of this launch and Semler Scientific assumes no obligation to replace or revise these statements until in any other case required by legislation.
INVESTOR CONTACT:
Renae Cormier
Chief Monetary Officer
[email protected]
SOURCE Semler Scientific, Inc.